These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8521580)

  • 21. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
    Edling O; Bao G; Feelisch M; Unger T; Gohlke P
    J Pharmacol Exp Ther; 1995 Nov; 275(2):854-63. PubMed ID: 7473177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute and long-term dose-response study of quinapril on hormonal profile and tissue angiotensin-converting enzyme in Wistar rats.
    Schaison FH; Fernando Ramirez-Gil J; Ciferri S; Bernard M; Baudin B; Mougenot N; Carayon A; Lechat P
    J Cardiovasc Pharmacol; 1996 Jul; 28(1):11-8. PubMed ID: 8797130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential suppression of pressure-overload cardiac and aortic hypertrophy in rats by angiotensin-converting enzyme inhibitors.
    Wang DQ; Kakizoe E; Kobayashi Y; Shimoura K; Okunishi H
    Jpn J Pharmacol; 1999 Aug; 80(4):333-42. PubMed ID: 10496334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effects of quinapril with enalapril in rats with heart failure.
    Watanabe K; Ma M; Wen J; Tachikawa H; Kodama M; Aizawa Y; Yamaguchi K; Takahashi T
    Pharmacology; 2004 Jul; 71(3):157-61. PubMed ID: 15161998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition.
    Keuneke C; Yacullo R; Metzger R; Hellmann T; Peters J; Ganten D
    Eur Heart J; 1990 May; 11 Suppl D():11-6. PubMed ID: 2163328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
    Schieffer B; Wirger A; Meybrunn M; Seitz S; Holtz J; Riede UN; Drexler H
    Circulation; 1994 May; 89(5):2273-82. PubMed ID: 8181153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.
    Ocaranza MP; Godoy I; Jalil JE; Varas M; Collantes P; Pinto M; Roman M; Ramirez C; Copaja M; Diaz-Araya G; Castro P; Lavandero S
    Hypertension; 2006 Oct; 48(4):572-8. PubMed ID: 16908757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renin-angiotensin system and minoxidil-induced cardiac hypertrophy in rats.
    Ruzicka M; Leenen FH
    Am J Physiol; 1993 Nov; 265(5 Pt 2):H1551-6. PubMed ID: 8238566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of angiotensin converting enzyme inhibitors on lipid peroxidation in sera and aorta of rabbits in diet-induced hypercholesterolemia.
    Wojakowski W; Gminski J; Siemianowicz K; Goss M; Machalski M
    Int J Mol Med; 2000 Nov; 6(5):591-4. PubMed ID: 11029530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preservation of cardiac function and energy reserve by the angiotensin-converting enzyme inhibitor quinapril during postmyocardial infarction remodeling in the rat.
    Hügel S; Horn M; Remkes H; Dienesch C; Neubauer S
    J Cardiovasc Magn Reson; 2001; 3(3):215-25. PubMed ID: 11816618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variation in angiotensin-converting enzyme does not prevent development of cardiac hypertrophy or upregulation of angiotensin II in response to aortocaval fistula.
    Perry GJ; Mori T; Wei CC; Xu XY; Chen YF; Oparil S; Lucchesi P; Dell'Italia LJ
    Circulation; 2001 Feb; 103(7):1012-6. PubMed ID: 11181478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ventricular remodeling after myocardial infarction and effects of ACE inhibition on hemodynamics and scar formation in SHR.
    Zdrojewski T; Gaudron P; Whittaker P; Poelzl S; Schiemann J; Hu K; Ertl G
    Cardiovasc Pathol; 2002; 11(2):88-93. PubMed ID: 11934599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
    Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
    Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quinapril, an angiotensin converting enzyme inhibitor, prevents cardiac hypertrophy during episodic hypertension.
    Julius S; Li Y; Brant D; Krause L; Taylor D
    Hypertension; 1991 Jun; 17(6 Pt 2):1161-6. PubMed ID: 1828458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic low-dose treatment with enalapril induced cardiac regression of left ventricular hypertrophy.
    Makino N; Sugano M; Hata T; Taguchi S; Yanaga T
    Mol Cell Biochem; 1996; 163-164():239-45. PubMed ID: 8974063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.
    Zolk O; Flesch M; Schnabel P; Teisman AC; Pinto YM; van Gilst WH; Paul M; Böhm M
    Br J Pharmacol; 1998 Feb; 123(3):405-12. PubMed ID: 9504380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glomerular hemodynamics in aortocaval fistula rats: role of renin-angiotensin system.
    Nishikimi T; Frohlich ED
    Am J Physiol; 1993 Apr; 264(4 Pt 2):R681-6. PubMed ID: 8476110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive cardiac dysfunction and fibrosis in the cardiomyopathic hamster and effects of growth hormone and angiotensin-converting enzyme inhibition.
    Ryoke T; Gu Y; Mao L; Hongo M; Clark RG; Peterson KL; Ross J
    Circulation; 1999 Oct; 100(16):1734-43. PubMed ID: 10525494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attenuation by ACE inhibitor drugs of alpha-adrenoceptor sensitivity in human vessels: possible differences related to drug lipophilicity.
    Kimura M; Umemura K; Kosuge K; Nishimoto M; Ohashi K; Nakashima M
    Br J Clin Pharmacol; 1998 Dec; 46(6):599-603. PubMed ID: 9862250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mechanism of the angiotensin-converting enzyme inhibitor quinapril is not related to bradykinin level in heart tissue.
    Barthelemy C; Eurin J; Lechat P; Masson F; Cortines M; Mougenot N; Soualmia H; Carayon A
    Peptides; 2002 Jun; 23(6):1161-9. PubMed ID: 12126746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.